SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-215050
Filing Date
2022-08-08
Accepted
2022-08-08 17:13:57
Documents
14
Period of Report
2022-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d345162d8k.htm   iXBRL 8-K 33526
2 EX-10.1 d345162dex101.htm EX-10.1 240217
3 EX-10.2 d345162dex102.htm EX-10.2 86708
  Complete submission text file 0001193125-22-215050.txt   569849

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstv-20220802.xsd EX-101.SCH 2883
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20220802_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20220802_pre.xml EX-101.PRE 11279
8 EXTRACTED XBRL INSTANCE DOCUMENT d345162d8k_htm.xml XML 3389
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

IRS No.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 221145391
SIC: 3841 Surgical & Medical Instruments & Apparatus